Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ardelyx Outlines Next Phase III Steps For Tenapanor, Ditches RDX7675

Nov 21 2017

• By Emily Hayes

Yellow road sign with a blue sky and white clouds: clinical trial

Related Content

Ardelyx's Adjusted Trial Design May Expedite NDA Filing For Lead Candidate

Jun 22 2016

Ardelyx's Tenapanor Data Challenge Phosphate Binders In Hyperphosphatemia

Feb 17 2017

Related Companies

Ardelyx Inc.

Sanofi

Keryx Biopharmaceuticals Inc.

Additional Topics

Business Strategies Clinical Trials Regulation Research & Development BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window